Role of gap junctional intercellular communication on the cytotoxic effect of anticancer drug
间隙连接细胞间通讯在抗癌药物细胞毒作用中的作用
基本信息
- 批准号:16591377
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We investigate the role of gap junctional intercellular communication(GJIC)on the cytotoxic effect of an anticancer drug, docetaxel, in esophageal cancer cell line.RT-PCR and Western blot analysis revealed that human esophageal cancer cell line, KE-10, didn't have expression of any connexin (Cx) and GJIC capacity. Cx32 gene was transfected into the cells. Cx32 expression was confirmed with RT-PCR, Western blot and immunohistochemisty in the Cx32-transfected cells (KE-10/Cx32). KE-10/Cx32 showed the restoration of GJIC capacity with dye transfer assay and the cyotoxicity was enhanced by 30-40% compared with KE-10. Apoptosis was upregulated in KE-10/C32 cells. And MDR gene, which is responsible for the drug resistance of docetaxel, wasn't expressed in two cell lines. Finally, we investigated the effect of the GJIC inhibitor, carbenoxolone, on cytotoxic effect of docetaxel. Carbenoxolone decreased the cytotoxity of docetaxel in KE-10/Cx32 cells by 20%. These date suggest that GJIC is involved in the cytotoxic effect of docetaxel.
我们研究了缝隙连接细胞间通讯(GJIC)在抗癌药物多西紫杉醇对食管癌细胞系的细胞毒作用中的作用。RT-PCR和Western印迹分析表明,人食管癌细胞系KE-10不表达任何连接蛋白(Cx)和GJIC能力。将Cx32基因导入细胞。RT-PCR、Western印迹和免疫组织化学检测证实Cx32基因在KE-10/Cx32细胞中有表达。染料转移实验显示KE-10/Cx32细胞的GJIC活性恢复,细胞毒作用较KE-10细胞提高30-40%。KE-10/C32细胞凋亡上调。而导致多西紫杉醇耐药的MDR基因在两种细胞系中均未表达。最后,我们研究了GJIC抑制剂Carbenoxolone对多西紫杉醇细胞毒作用的影响。Carbenoxolone使多西紫杉醇对KE-10/Cx32细胞的毒性降低20%。提示GJIC参与了多西紫杉醇的细胞毒作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
                item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ patent.updateTime }}
TANAKA Toshiaki其他文献
TANAKA Toshiaki的其他文献
{{
              item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
{{ truncateString('TANAKA Toshiaki', 18)}}的其他基金
A study of new evaluation and training devices of standing balance ability with sensory stimulation for the elderly and the disabled persons
新型老年人及残疾人感觉刺激站立平衡能力评价训练装置的研究
- 批准号:24650346 
- 财政年份:2012
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Challenging Exploratory Research 
Relationship between inhibition of ID1 expression and induction of irreversible suppression of cell proliferation in HepG2 hepatoma cells treated with HGF
HGF处理的HepG2肝癌细胞中ID1表达抑制与诱导细胞增殖不可逆抑制的关系
- 批准号:22570137 
- 财政年份:2010
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Scientific Research (C) 
All-inclusive research on the Historical deployment of each country in KAYA 加耶 and the real phase of countries union in KAYA 加耶.
全方位研究KAYA卡亚各个国家的历史部署以及KAYA卡亚国家联盟的真实阶段。
- 批准号:22520718 
- 财政年份:2010
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Scientific Research (C) 
A study of development of three-dimensional visual barrier-free device for individual locomotion with visual perceptual disorders
视知觉障碍个体运动三维视觉无障碍装置的研制
- 批准号:22650135 
- 财政年份:2010
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Challenging Exploratory Research 
Surveillance study about the position, the structure, and the function of the double capital or the subcapital in a Korean history
双都或副都在韩国历史上的地位、结构和功能的监测研究
- 批准号:22401031 
- 财政年份:2010
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Scientific Research (B) 
Functional analysis and clinical application of PHD3 in renal cell carcinoma
PHD3在肾细胞癌中的功能分析及临床应用
- 批准号:22791477 
- 财政年份:2010
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Young Scientists (B) 
A study of new assistive device of standing balance and gait with sensory stimulation for the elderly and the disabled persons
新型老年人及残疾人感觉刺激站立平衡步态辅助器的研究
- 批准号:22240068 
- 财政年份:2010
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Scientific Research (A) 
An assistive engineering study of barrier-free device for patient with visuo-spatial cognitive deficits by new method of visual information.
视觉信息新方法对视觉空间认知缺陷患者无障碍装置的辅助工程研究
- 批准号:19300203 
- 财政年份:2007
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Scientific Research (B) 
Signaling mechanism of antiproliferative effect of HGF on carcinoma cells
HGF抗癌细胞增殖作用的信号机制
- 批准号:19570124 
- 财政年份:2007
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Scientific Research (C) 
A basic study of new sensory feedback system for postural control by use of a mixed reality technology
利用混合现实技术进行姿势控制的新型感觉反馈系统的基础研究
- 批准号:17603001 
- 财政年份:2005
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Scientific Research (C) 
相似国自然基金
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
- 批准号:82304565
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于Notch-1介导miR-200家族调控上皮间质转化对绒癌耐药机制的研究
- 批准号:81972428
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
地塞米松诱导的人卵巢癌对化疗药物耐受及其机制的研究
- 批准号:81172471
- 批准年份:2011
- 资助金额:57.0 万元
- 项目类别:面上项目
维生素B3促进化疗导致粒细胞减少症的中性粒细胞生成功能及作用机制研究
- 批准号:81060045
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
番荔枝内酯抗肿瘤作用及调节肿瘤耐药分子调控网络研究
- 批准号:30973854
- 批准年份:2009
- 资助金额:20.0 万元
- 项目类别:面上项目
应用蛋白敲除技术降解ErbB家族的抗乳腺癌作用及其机制研究
- 批准号:30901754
- 批准年份:2009
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
卵巢癌肿瘤干细胞特异性microRNA分子靶点调控的研究
- 批准号:30873011
- 批准年份:2008
- 资助金额:34.0 万元
- 项目类别:面上项目
巨噬细胞诱导的大肠癌靶向治疗实验研究
- 批准号:30471998
- 批准年份:2004
- 资助金额:20.0 万元
- 项目类别:面上项目
相似海外基金
I-Corps: Translation potential of using machine learning to predict oxaliplatin chemotherapy benefit in early colon cancer
I-Corps:利用机器学习预测奥沙利铂化疗对早期结肠癌疗效的转化潜力
- 批准号:2425300 
- 财政年份:2024
- 资助金额:$ 2.05万 
- 项目类别:Standard Grant 
Investigation on naphthylisoquinoline alkaloids as potential antiausterity chemotherapy for pancreatic cancer
萘基异喹啉生物碱作为胰腺癌潜在抗紧缩化疗的研究
- 批准号:23K26797 
- 财政年份:2024
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Scientific Research (B) 
A novel medical device for reducing chemotherapy-induced peripheral neuropathy in the hands
一种减少化疗引起的手部周围神经病变的新型医疗设备
- 批准号:MR/Z503800/1 
- 财政年份:2024
- 资助金额:$ 2.05万 
- 项目类别:Research Grant 
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:10481965 
- 财政年份:2024
- 资助金额:$ 2.05万 
- 项目类别:
Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
- 批准号:10991546 
- 财政年份:2024
- 资助金额:$ 2.05万 
- 项目类别:
Protecting spermatogonial stem cells from chemotherapy-induced damage for fertility preservation in childhood cancer
保护精原干细胞免受化疗引起的损伤,以保存儿童癌症的生育能力
- 批准号:MR/Y011783/1 
- 财政年份:2024
- 资助金额:$ 2.05万 
- 项目类别:Fellowship 
Role of CD44 bearing TJA-II binding glycans in therapy-resistant subset of triple negative breast cancer
携带 CD44 的 TJA-II 结合聚糖在三阴性乳腺癌耐药亚型中的作用
- 批准号:23K06748 
- 财政年份:2023
- 资助金额:$ 2.05万 
- 项目类别:Grant-in-Aid for Scientific Research (C) 
Bone Marrow Adipogenesis in Response to Chemotherapy and Resultant Effect on Bone Metastasis
骨髓脂肪生成对化疗的反应及其对骨转移的影响
- 批准号:491636 
- 财政年份:2023
- 资助金额:$ 2.05万 
- 项目类别:Miscellaneous Programs 
225Ac-labeled anti-nectin-4 radioimmunoconjugate with/without immune checkpoint blockage in triple negative breast cancer.
225Ac 标记的抗 nectin-4 放射免疫缀合物,有/没有免疫检查点阻断治疗三阴性乳腺癌。
- 批准号:488261 
- 财政年份:2023
- 资助金额:$ 2.05万 
- 项目类别:Operating Grants 
Investigating the Role of Drug Tolerant Persisters in Driving Colorectal Cancer Metastasis.
研究耐药性持续存在在驱动结直肠癌转移中的作用。
- 批准号:491461 
- 财政年份:2023
- 资助金额:$ 2.05万 
- 项目类别:Fellowship Programs 

 刷新
              刷新
            
















 {{item.name}}会员
              {{item.name}}会员
            



